SAN DIEGO— Entest BioMedical, a company developing an immunotherapeutic cancer treatment for dogs, signed a letter of intent to buy
three veterinary hospitals in Orange County.
The company reports the acquisition will generate about $900,000 in new revenue and will help the company execute on its strategic
goal of creating a network of animal hospitals, In January, the company closed on the purchase of Santa Barbara's McDonald
Animal Hospital. These acquisitions are estimated at bringing Entest revenues of about $2 million a year in the veterinary
hospital segment.
"Initially, Entest plans on focusing on veterinary acquisition candidates in California, with future plans to expand into
other states," company officials say.
Last November, Entest unveiled a safety study for an immunotherapeutic cancer vaccine for dogs currently in development. Entest
also initiated a collaboration with RenovoCyte LLC and Medistem Inc. to explore the development of a stem-cell therapy for
treating hip dysplasia in dogs. 
Featuring Information from:
